CD4+ T cell expression of MyD88 is essential for normal resolution of chlamydia muridarum genital tract infection

Journal of Immunology

Volumn 191, Issue 8, 2013, Pages 4269-4279

  Frazer, Lauren C ^a,b   Sullivan, Jeanne E ^b   Zurenski, Matthew A ^b   Mintus, Margaret ^b   Tomasak, Tammy E ^b   Prantner, Daniel ^c   Nagarajan, Uma M ^b   Darville, Toni ^a,b  

^a UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

^b CHILDREN S HOSPITAL OF PITTSBURGH   (United States)

^c UNIVERSITY OF MARYLAND SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

INTERLEUKIN 1 RECEPTOR; MYELOID DIFFERENTIATION FACTOR 88; TOLL LIKE RECEPTOR;

ADAPTIVE IMMUNITY; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; APOPTOSIS; ARTICLE; CD4+ T LYMPHOCYTE; CELLULAR DISTRIBUTION; CHLAMYDIASIS; CONTROLLED STUDY; FEMALE; FEMALE GENITAL TRACT INFECTION; IN VITRO STUDY; IN VIVO STUDY; INFECTION CONTROL; INNATE IMMUNITY; LYMPHOCYTE ACTIVATION; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; SIGNAL TRANSDUCTION;

ADOPTIVE TRANSFER; ANIMALS; BONE MARROW; CD4-POSITIVE T-LYMPHOCYTES; CHLAMYDIA INFECTIONS; CHLAMYDIA MURIDARUM; FEMALE; GENITALIA, FEMALE; LYMPH NODES; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; MYELOID DIFFERENTIATION FACTOR 88; RECEPTORS, INTERLEUKIN-1; REPRODUCTIVE TRACT INFECTIONS;

EID: 84885448570     PISSN: 00221767     EISSN: 15506606     Source Type: Journal    
DOI: 10.4049/jimmunol.1301547     Document Type: Article

References (92)

1. Haggerty, C. L., S. L. Gottlieb, B. D. Taylor, N. Low, F. Xu, and R. B. Ness. 2010. Risk of sequelae after Chlamydia trachomatis genital infection in women. J. Infect. Dis. 201(Suppl. 2): S134-S155.
2. Lee, H. Y., J. H. Schripsema, I. M. Sigar, S. R. Lacy, J. N. Kasimos, C. M. Murray, and K. H. Ramsey. 2010. A role for CXC chemokine receptor-2 in the pathogenesis of urogenital Chlamydia muridarum infection in mice. FEMS Immunol. Med. Microbiol. 60: 49-56.
3. Imtiaz, M. T., J. T. Distelhorst, J. H. Schripsema, I. M. Sigar, J. N. Kasimos, S. R. Lacy, and K. H. Ramsey. 2007. A role for matrix metalloproteinase-9 in pathogenesis of urogenital Chlamydia muridarum infection in mice. Microbes Infect. 9: 1561-1566.
4. Lacy, H. M., A. K. Bowlin, L. Hennings, A. M. Scurlock, U. M. Nagarajan, and R. G. Rank. 2011. Essential role for neutrophils in pathogenesis and adaptive immunity in Chlamydia caviae ocular infections. Infect. Immun. 79: 1889-1897.
5. Darville, T., J. M. O'Neill, C. W. Andrews, Jr., U. M. Nagarajan, L. Stahl, and D. M. Ojcius. 2003. Toll-like receptor-2, but not Toll-like receptor-4, is essential for development of oviduct pathology in chlamydial genital tract infection. J. Immunol. 171: 6187-6197.
6. Frazer, L. C., C. M. O'Connell, C. W. Andrews, Jr., M. A. Zurenski, and T. Darville. 2011. Enhanced neutrophil longevity and recruitment contribute to the severity of oviduct pathology during Chlamydia muridarum infection. Infect. Immun. 79: 4029-4041.
7. Rank, R. G., L. S. Soderberg, and A. L. Barron. 1985. Chronic chlamydial genital infection in congenitally athymic nude mice. Infect. Immun. 48: 847-849.
8. Morrison, S. G., H. Su, H. D. Caldwell, and R. P. Morrison. 2000. Immunity to murine Chlamydia trachomatis genital tract reinfection involves B cells and CD4+ T cells but not CD8+ T cells. Infect. Immun. 68: 6979-6987.
9. Igietseme, J. U., K. H. Ramsey, D. M. Magee, D. M. Williams, T. J. Kincy, and R. G. Rank. 1993. Resolution of murine chlamydial genital infection by the adoptive transfer of a biovar-specific, Th1 lymphocyte clone. Reg. Immunol. 5: 317-324.
10. Morrison, R. P., K. Feilzer, and D. B. Tumas. 1995. Gene knockout mice establish a primary protective role for major histocompatibility complex class IIrestricted responses in Chlamydia trachomatis genital tract infection. Infect. Immun. 63: 4661-4668.
11. Cain, T. K., and R. G. Rank. 1995. Local Th1-like responses are induced by intravaginal infection of mice with the mouse pneumonitis biovar of Chlamydia trachomatis. Infect. Immun. 63: 1784-1789.
12. Perry, L. L., K. Feilzer, and H. D. Caldwell. 1997. Immunity to Chlamydia trachomatis is mediated by T helper 1 cells through IFN-g-dependent and-independent pathways. J. Immunol. 158: 3344-3352.
13. Cotter, T. W., K. H. Ramsey, G. S. Miranpuri, C. E. Poulsen, and G. I. Byrne. 1997. Dissemination of Chlamydia trachomatis chronic genital tract infection in g interferon gene knockout mice. Infect. Immun. 65: 2145-2152.
14. Cohen, C. R., K. M. Koochesfahani, A. S. Meier, C. Shen, K. Karunakaran, B. Ondondo, T. Kinyari, N. R. Mugo, R. Nguti, and R. C. Brunham. 2005. Immunoepidemiologic profile of Chlamydia trachomatis infection: importance of heat-shock protein 60 and interferon-g. J. Infect. Dis. 192: 591-599.
15. Debattista, J., P. Timms, J. Allan, and J. Allan. 2002. Reduced levels of g-interferon secretion in response to chlamydial 60 kDa heat shock protein amongst women with pelvic inflammatory disease and a history of repeated Chlamydia trachomatis infections. Immunol. Lett. 81: 205-210.
16. Kimani, J., I. W. Maclean, J. J. Bwayo, K. MacDonald, J. Oyugi, G. M. Maitha, R. W. Peeling, M. Cheang, N. J. Nagelkerke, F. A. Plummer, and R. C. Brunham. 1996. Risk factors for Chlamydia trachomatis pelvic inflammatory disease among sex workers in Nairobi, Kenya. J. Infect. Dis. 173: 1437-1444.
17. Igietseme, J. U., I. M. Uriri, R. Hawkins, and R. G. Rank. 1996. Integrinmediated epithelial-T cell interaction enhances nitric oxide production and increased intracellular inhibition of Chlamydia. J. Leukoc. Biol. 59: 656-662.
18. Jayarapu, K., M. Kerr, S. Ofner, and R. M. Johnson. 2010. Chlamydia-specific CD4 T cell clones control Chlamydia muridarum replication in epithelial cells by nitric oxide-dependent and-independent mechanisms. J. Immunol. 185: 6911-6920.
19. Pasare, C., and R. Medzhitov. 2004. Toll-dependent control mechanisms of CD4 T cell activation. Immunity 21: 733-741.
20. O'Connell, C. M., I. A. Ionova, A. J. Quayle, A. Visintin, and R. R. Ingalls. 2006. Localization of TLR2 and MyD88 to Chlamydia trachomatis inclusions: evidence for signaling by intracellular TLR2 during infection with an obligate intracellular pathogen. J. Biol. Chem. 281: 1652-1659.
21. Derbigny, W. A., S. C. Hong, M. S. Kerr, M. Temkit, and R. M. Johnson. 2007. Chlamydia muridarum infection elicits a b interferon response in murine oviduct epithelial cells dependent on interferon regulatory factor 3 and TRIF. Infect. Immun. 75: 1280-1290.
22. Bulut, Y., E. Faure, L. Thomas, H. Karahashi, K. S. Michelsen, O. Equils, S. G. Morrison, R. P. Morrison, and M. Arditi. 2002. Chlamydial heat shock protein 60 activates macrophages and endothelial cells through Toll-like receptor 4 and MD2 in a MyD88-dependent pathway. J. Immunol. 168: 1435-1440.
23. Heine, H., S. Müller-Loennies, L. Brade, B. Lindner, and H. Brade. 2003. Endotoxic activity and chemical structure of lipopolysaccharides from Chlamydia trachomatis serotypes E and L2 and Chlamydophila psittaci 6BC. Eur. J. Biochem. 270: 440-450.
24. Welter-Stahl, L., D. M. Ojcius, J. Viala, S. Girardin, W. Liu, C. Delarbre, D. Philpott, K. A. Kelly, and T. Darville. 2006. Stimulation of the cytosolic receptor for peptidoglycan, Nod1, by infection with Chlamydia trachomatis or Chlamydia muridarum. Cell. Microbiol. 8: 1047-1057.
25. Ozinsky, A., D. M. Underhill, J. D. Fontenot, A. M. Hajjar, K. D. Smith, C. B. Wilson, L. Schroeder, and A. Aderem. 2000. The repertoire for pattern recognition of pathogens by the innate immune system is defined by cooperation between Toll-like receptors. Proc. Natl. Acad. Sci. USA 97: 13766-13771.
26. Taylor, B. D., T. Darville, R. E. Ferrell, C. M. Kammerer, R. B. Ness, and C. L. Haggerty. 2012. Variants in toll-like receptor 1 and 4 genes are associated with Chlamydia trachomatis among women with pelvic inflammatory disease. J. Infect. Dis. 205: 603-609.
27. den Hartog, J. E., J. M. Lyons, S. Ouburg, J. S. Fennema, H. J. de Vries, C. A. Bruggeman, J. I. Ito, A. S. Pena, J. A. Land, and S. A. Morre. 2009. TLR4 in Chlamydia trachomatis infections: knockout mice, STD patients and women with tubal factor subfertility. Drugs Today 45(Suppl. B): 75-82.
28. Adachi, O., T. Kawai, K. Takeda, M. Matsumoto, H. Tsutsui, M. Sakagami, K. Nakanishi, and S. Akira. 1998. Targeted disruption of the MyD88 gene results in loss of IL-1- and IL-18-mediated function. Immunity 9: 143-150.
29. Medzhitov, R., P. Preston-Hurlburt, E. Kopp, A. Stadlen, C. Chen, S. Ghosh, and C. A. Janeway, Jr. 1998. MyD88 is an adaptor protein in the hToll/IL-1 receptor family signaling pathways. Mol. Cell 2: 253-258.
30. Jiang, Z., T. W. Mak, G. Sen, and X. Li. 2004. Toll-like receptor 3-mediated activation of NF-kB and IRF3 diverges at Toll-IL-1 receptor domain-containing adapter inducing IFN-b. Proc. Natl. Acad. Sci. USA 101: 3533-3538.
31. Kawai, T., O. Adachi, T. Ogawa, K. Takeda, and S. Akira. 1999. Unresponsiveness of MyD88-deficient mice to endotoxin. Immunity 11: 115-122.
32. Schmitz, J., A. Owyang, E. Oldham, Y. Song, E. Murphy, T. K. McClanahan, G. Zurawski, M. Moshrefi, J. Qin, X. Li, et al. 2005. IL-33, an interleukin-1-like cytokine that signals via the IL-1 receptor-related protein ST2 and induces T helper type 2-Associated cytokines. Immunity 23: 479-490.
33. Latz, E., A. Verma, A. Visintin, M. Gong, C. M. Sirois, D. C. Klein, B. G. Monks, C. J. McKnight, M. S. Lamphier, W. P. Duprex, et al. 2007. Ligand-induced conformational changes allosterically activate Toll-like receptor 9. Nat. Immunol. 8: 772-779.
34. Motshwene, P. G., M. C. Moncrieffe, J. G. Grossmann, C. Kao, M. Ayaluru, A. M. Sandercock, C. V. Robinson, E. Latz, and N. J. Gay. 2009. An oligomeric signaling platform formed by the Toll-like receptor signal transducers MyD88 and IRAK-4. J. Biol. Chem. 284: 25404-25411.
35. Tsukamoto, H., K. Fukudome, S. Takao, N. Tsuneyoshi, and M. Kimoto. 2010. Lipopolysaccharide-binding protein-mediated Toll-like receptor 4 dimerization enables rapid signal transduction against lipopolysaccharide stimulation on membrane-Associated CD14-expressing cells. Int. Immunol. 22: 271-280.
36. Burns, K., F. Martinon, C. Esslinger, H. Pahl, P. Schneider, J. L. Bodmer, F. Di Marco, L. French, and J. Tschopp. 1998. MyD88, an adapter protein involved in interleukin-1 signaling. J. Biol. Chem. 273: 12203-12209.
37. Suzuki, N., S. Suzuki, G. S. Duncan, D. G. Millar, T. Wada, C. Mirtsos, H. Takada, A. Wakeham, A. Itie, S. Li, et al. 2002. Severe impairment of interleukin-1 and Toll-like receptor signalling in mice lacking IRAK-4. Nature 416: 750-756.
38. Muzio, M., J. Ni, P. Feng, and V. M. Dixit. 1997. IRAK (Pelle) family member IRAK-2 and MyD88 as proximal mediators of IL-1 signaling. Science 278: 1612-1615.
39. Lin, S. C., Y. C. Lo, and H. Wu. 2010. Helical assembly in the MyD88-IRAK4-IRAK2 complex in TLR/IL-1R signalling. Nature 465: 885-890.
40. von Bernuth, H., C. Picard, A. Puel, and J. L. Casanova. 2012. Experimental and natural infections in MyD88-And IRAK-4-deficient mice and humans. Eur. J. Immunol. 42: 3126-3135.
41. von Bernuth, H., C. Picard, Z. Jin, R. Pankla, H. Xiao, C. L. Ku, M. Chrabieh, I. B. Mustapha, P. Ghandil, Y. Camcioglu, et al. 2008. Pyogenic bacterial infections in humans with MyD88 deficiency. Science 321: 691-696.
42. Picard, C., A. Puel, M. Bonnet, C. L. Ku, J. Bustamante, K. Yang, C. Soudais, S. Dupuis, J. Feinberg, C. Fieschi, et al. 2003. Pyogenic bacterial infections in humans with IRAK-4 deficiency. Science 299: 2076-2079.
43. LaRosa, D. F., J. S. Stumhofer, A. E. Gelman, A. H. Rahman, D. K. Taylor, C. A. Hunter, and L. A. Turka. 2008. T cell expression of MyD88 is required for resistance to Toxoplasma gondii. Proc. Natl. Acad. Sci. USA 105: 3855-3860.
44. Zhou, S., E. A. Kurt-Jones, A. M. Cerny, M. Chan, R. T. Bronson, and R. W. Finberg. 2009. MyD88 intrinsically regulates CD4 T-cell responses. J. Virol. 83: 1625-1634.
45. Rahman, A. H., W. Cui, D. F. Larosa, D. K. Taylor, J. Zhang, D. R. Goldstein, E. J. Wherry, S. M. Kaech, and L. A. Turka. 2008. MyD88 plays a critical T cellintrinsic role in supporting CD8 T cell expansion during acute lymphocytic choriomeningitis virus infection. J. Immunol. 181: 3804-3810.
46. Fukata, M., K. Breglio, A. Chen, A. S. Vamadevan, T. Goo, D. Hsu, D. Conduah, R. Xu, and M. T. Abreu. 2008. The myeloid differentiation factor 88 (MyD88) is required for CD4+ T cell effector function in a murine model of inflammatory bowel disease. J. Immunol. 180: 1886-1894.
47. Tomita, T., T. Kanai, T. Fujii, Y. Nemoto, R. Okamoto, K. Tsuchiya, T. Totsuka, N. Sakamoto, S. Akira, and M. Watanabe. 2008. MyD88-dependent pathway in T cells directly modulates the expansion of colitogenic CD4+ T cells in chronic colitis. J. Immunol. 180: 5291-5299.
48. Chang, J., P. R. Burkett, C. M. Borges, V. K. Kuchroo, L. A. Turka, and C. H. Chang. 2013. MyD88 is essential to sustain mTOR activation necessary to promote T helper 17 cell proliferation by linking IL-1 and IL-23 signaling. Proc. Natl. Acad. Sci. USA 110: 2270-2275.
49. Imanishi, T., H. Hara, S. Suzuki, N. Suzuki, S. Akira, and T. Saito. 2007. Cutting edge: TLR2 directly triggers Th1 effector functions. J. Immunol. 178: 6715-6719.
50. Gelman, A. E., J. Zhang, Y. Choi, and L. A. Turka. 2004. Toll-like receptor ligands directly promote activated CD4+ T cell survival. J. Immunol. 172: 6065-6073.
51. Reynolds, J. M., G. J. Martinez, Y. Chung, and C. Dong. 2012. Toll-like receptor 4 signaling in T cells promotes autoimmune inflammation. Proc. Natl. Acad. Sci. USA 109: 13064-13069.
52. Caron, G., D. Duluc, I. Frémaux, P. Jeannin, C. David, H. Gascan, and Y. Delneste. 2005. Direct stimulation of human T cells via TLR5 and TLR7/8: flagellin and R-848 up-regulate proliferation and IFN-g production by memory CD4+ T cells. J. Immunol. 175: 1551-1557.
53. Takeda, K., H. Tsutsui, T. Yoshimoto, O. Adachi, N. Yoshida, T. Kishimoto, H. Okamura, K. Nakanishi, and S. Akira. 1998. Defective NK cell activity and Th1 response in IL-18-deficient mice. Immunity 8: 383-390.
54. Tominaga, K., T. Yoshimoto, K. Torigoe, M. Kurimoto, K. Matsui, T. Hada, H. Okamura, and K. Nakanishi. 2000. IL-12 synergizes with IL-18 or IL-1b for IFN-g production from human T cells. Int. Immunol. 12: 151-160.
55. Nagarajan, U. M., D. M. Ojcius, L. Stahl, R. G. Rank, and T. Darville. 2005. Chlamydia trachomatis induces expression of IFN-g-inducible protein 10 and IFN-b independent of TLR2 and TLR4, but largely dependent on MyD88. J. Immunol. 175: 450-460.
56. Derbigny, W. A., M. S. Kerr, and R. M. Johnson. 2005. Pattern recognition molecules activated by Chlamydia muridarum infection of cloned murine oviduct epithelial cell lines. J. Immunol. 175: 6065-6075.
57. Chen, L., L. Lei, X. Chang, Z. Li, C. Lu, X. Zhang, Y. Wu, I. T. Yeh, and G. Zhong. 2010. Mice deficient in MyD88 Develop a Th2-dominant response and severe pathology in the upper genital tract following Chlamydia muridarum infection. J. Immunol. 184: 2602-2610.
58. Nagarajan, U. M., J. Sikes, D. Prantner, C. W. Andrews, Jr., L. Frazer, A. Goodwin, J. N. Snowden, and T. Darville. 2011. MyD88 deficiency leads to decreased NK cell g interferon production and T cell recruitment during Chlamydia muridarum genital tract infection, but a predominant Th1 response and enhanced monocytic inflammation are associated with infection resolution. Infect. Immun. 79: 486-498.
59. Nagarajan, U. M., J. D. Sikes, L. Yeruva, and D. Prantner. 2012. Significant role of IL-1 signaling, but limited role of inflammasome activation, in oviduct pathology during Chlamydia muridarum genital infection. J. Immunol. 188: 2866-2875.
60. Riley, M. M., M. A. Zurenski, L. C. Frazer, C. M. O'Connell, C. W. Andrews, Jr., M. Mintus, and T. Darville. 2012. The recall response induced by genital challenge with Chlamydia muridarum protects the oviduct from pathology but not from reinfection. Infect. Immun. 80: 2194-2203.
61. Gondek, D. C., A. J. Olive, G. Stary, and M. N. Starnbach. 2012. CD4+ T cells are necessary and sufficient to confer protection against Chlamydia trachomatis infection in the murine upper genital tract. J. Immunol. 189: 2441-2449.
62. O'Connell, C. M., R. R. Ingalls, C. W. Andrews, Jr., A. M. Scurlock, and T. Darville. 2007. Plasmid-deficient Chlamydia muridarum fail to induce immune pathology and protect against oviduct disease. J. Immunol. 179: 4027-4034.
63. O'Connell, C. M., and K. M. Nicks. 2006. A plasmid-cured Chlamydia muridarum strain displays altered plaque morphology and reduced infectivity in cell culture. Microbiology 152: 1601-1607.
64. O'Connell, C. M., Y. M. AbdelRahman, E. Green, H. K. Darville, K. Saira, B. Smith, T. Darville, A. M. Scurlock, C. R. Meyer, and R. J. Belland. 2011. Toll-like receptor 2 activation by Chlamydia trachomatis is plasmid dependent, and plasmid-responsive chromosomal loci are coordinately regulated in response to glucose limitation by C. trachomatis but not by C. muridarum. Infect. Immun. 79: 1044-1056.
65. Darville, T., C. W. Andrews, Jr., K. K. Laffoon,W. Shymasani, L. R. Kishen, and R. G. Rank. 1997. Mouse strain-dependent variation in the course and outcome of chlamydial genital tract infection is associated with differences in host response. Infect. Immun. 65: 3065-3073.
66. Hemmi, H., T. Kaisho, O. Takeuchi, S. Sato, H. Sanjo, K. Hoshino, T. Horiuchi, H. Tomizawa, K. Takeda, and S. Akira. 2002. Small anti-viral compounds activate immune cells via the TLR7 MyD88-dependent signaling pathway. Nat. Immunol. 3: 196-200.
67. Hemmi, H., O. Takeuchi, T. Kawai, T. Kaisho, S. Sato, H. Sanjo, M. Matsumoto, K. Hoshino, H. Wagner, K. Takeda, and S. Akira. 2000. A Toll-like receptor recognizes bacterial DNA. Nature 408: 740-745.
68. Tuffrey, M., and D. Taylor-Robinson. 1981. Progesterone as a key factor in the development of a mouse model for genital-tract infection with Chlamydia trachomatis. FEMS Microbiol. Lett. 12: 111-115.
69. Kelly, K. A., E. A. Robinson, and R. G. Rank. 1996. Initial route of antigen administration alters the T-cell cytokine profile produced in response to the mouse pneumonitis biovar of Chlamydia trachomatis following genital infection. [Published erratum appears in 1997 Infect. Immun. 65: 2508.] Infect. Immun. 64: 4976-4983.
70. Scurlock, A. M., L. C. Frazer, C. W. Andrews, Jr., C. M. O'Connell, I. P. Foote, S. L. Bailey, K. Chandra-Kuntal, J. K. Kolls, and T. Darville. 2011. Interleukin-17 contributes to generation of Th1 immunity and neutrophil recruitment during Chlamydia muridarum genital tract infection but is not required for macrophage influx or normal resolution of infection. Infect. Immun. 79: 1349-1362.
71. Swanson, J., D. A. Eschenbach, E. R. Alexander, and K. K. Holmes. 1975. Light and electron microscopic study of Chlamydia trachomatis infection of the uterine cervix. J. Infect. Dis. 131: 678-687.
72. Kiviat, N. B., P. Wølner-Hanssen, M. Peterson, J. Wasserheit, W. E. Stamm, D. A. Eschenbach, J. Paavonen, J. Lingenfelter, T. Bell, V. Zabriskie, et al. 1986. Localization of Chlamydia trachomatis infection by direct immunofluorescence and culture in pelvic inflammatory disease. Am. J. Obstet. Gynecol. 154: 865-873.
73. Morrison, R. P., and H. D. Caldwell. 2002. Immunity to murine chlamydial genital infection. Infect. Immun. 70: 2741-2751.
74. Rakoff-Nahoum, S., J. Paglino, F. Eslami-Varzaneh, S. Edberg, and R. Medzhitov. 2004. Recognition of commensal microflora by Toll-like receptors is required for intestinal homeostasis. Cell 118: 229-241.
75. Hao, W., Y. Liu, S. Liu, S. Walter, M. O. Grimm, A. J. Kiliaan, B. Penke, T. Hartmann, C. E. Rübe, M. D. Menger, and K. Fassbender. 2011. Myeloid differentiation factor 88-deficient bone marrow cells improve Alzheimer's disease-related symptoms and pathology. Brain 134: 278-292.
76. Zhang, Y., M. Jones, A. McCabe, G. M. Winslow, D. Avram, and K. C. MacNamara. 2013. MyD88 signaling in CD4 T cells promotes IFN-g production and hematopoietic progenitor cell expansion in response to intracellular bacterial infection. J. Immunol. 190: 4725-4735.
77. Rank, R. G., K. H. Ramsey, E. A. Pack, and D. M. Williams. 1992. Effect of g interferon on resolution of murine chlamydial genital infection. Infect. Immun. 60: 4427-4429.
78. Su, H., K. Feilzer, H. D. Caldwell, and R. P. Morrison. 1997. Chlamydia trachomatis genital tract infection of antibody-deficient gene knockout mice. Infect. Immun. 65: 1993-1999.
79. Derbigny, W. A., L. R. Shobe, J. C. Kamran, K. S. Toomey, and S. Ofner. 2012. Identifying a role for Toll-like receptor 3 in the innate immune response to Chlamydia muridarum infection in murine oviduct epithelial cells. Infect. Immun. 80: 254-265.
80. Mancuso, G., M. Gambuzza, A. Midiri, C. Biondo, S. Papasergi, S. Akira, G. Teti, and C. Beninati. 2009. Bacterial recognition by TLR7 in the lysosomes of conventional dendritic cells. Nat. Immunol. 10: 587-594.
81. Ouburg, S., J. M. Lyons, J. A. Land, J. E. den Hartog, J. S. Fennema, H. J. de Vries, C. A. Bruggeman, J. I. Ito, A. S. Pena, P. S. Lundberg, and S. A. Morre. 2009. TLR9 KO mice, haplotypes and CPG indices in Chlamydia trachomatis infection. Drugs Today 45(Suppl. B): 83-93.
82. Sun, D., and A. Ding. 2006. MyD88-mediated stabilization of interferong-induced cytokine and chemokine mRNA. Nat. Immunol. 7: 375-381.
83. Hvid, M., A. Baczynska, B. Deleuran, J. Fedder, H. J. Knudsen, G. Christiansen, and S. Birkelund. 2007. Interleukin-1 is the initiator of Fallopian tube destruction during Chlamydia trachomatis infection. Cell. Microbiol. 9: 2795-2803.
84. Kirkland, D., A. Benson, J. Mirpuri, R. Pifer, B. Hou, A. L. DeFranco, and F. Yarovinsky. 2012. B cell-intrinsic MyD88 signaling prevents the lethal dissemination of commensal bacteria during colonic damage. Immunity 36: 228-238.
85. Ojaniemi, M., V. Glumoff, K. Harju, M. Liljeroos, K. Vuori, and M. Hallman. 2003. Phosphatidylinositol 3-kinase is involved in Toll-like receptor 4-mediated cytokine expression in mouse macrophages. Eur. J. Immunol. 33: 597-605.
86. Gelman, A. E., D. F. LaRosa, J. Zhang, P. T. Walsh, Y. Choi, J. O. Sunyer, and L. A. Turka. 2006. The adaptor molecule MyD88 activates PI-3 kinase signaling in CD4+ T cells and enables CpG oligodeoxynucleotide-mediated costimulation. Immunity 25: 783-793.
87. Aliprantis, A. O., R. B. Yang, D. S. Weiss, P. Godowski, and A. Zychlinsky. 2000. The apoptotic signaling pathway activated by Toll-like receptor-2. EMBO J. 19: 3325-3336.
88. Horng, T., and R. Medzhitov. 2001. Drosophila MyD88 is an adapter in the Toll signaling pathway. Proc. Natl. Acad. Sci. USA 98: 12654-12658.
89. Negishi, H., Y. Fujita, H. Yanai, S. Sakaguchi, X. Ouyang, M. Shinohara, H. Takayanagi, Y. Ohba, T. Taniguchi, and K. Honda. 2006. Evidence for licensing of IFN-g-induced IFN regulatory factor 1 transcription factor by MyD88 in Toll-like receptor-dependent gene induction program. Proc. Natl. Acad. Sci. USA 103: 15136-15141.
90. Takaoka, A., H. Yanai, S. Kondo, G. Duncan, H. Negishi, T. Mizutani, S. Kano, K. Honda, Y. Ohba, T. W. Mak, and T. Taniguchi. 2005. Integral role of IRF-5 in the gene induction programme activated by Toll-like receptors. Nature 434: 243-249.
91. Honda, K., H. Yanai, T. Mizutani, H. Negishi, N. Shimada, N. Suzuki, Y. Ohba, A. Takaoka, W. C. Yeh, and T. Taniguchi. 2004. Role of a transductionaltranscriptional processor complex involving MyD88 and IRF-7 in Toll-like receptor signaling. Proc. Natl. Acad. Sci. USA 101: 15416-15421.
92. Bannerman, D. D., J. C. Tupper, J. D. Kelly, R. K. Winn, and J. M. Harlan. 2002. The Fas-Associated death domain protein suppresses activation of NF-kB by LPS and IL-1b. J. Clin. Invest. 109: 419-425.